1. The Promise of AI for DILI Prediction
- Author
-
Andreu Vall, Yogesh Sabnis, Jiye Shi, Reiner Class, Sepp Hochreiter, and Günter Klambauer
- Subjects
0301 basic medicine ,Modalities ,business.industry ,Computer science ,Deep learning ,Mini Review ,deep learning ,artificial intelligence ,neural networks ,Data science ,lcsh:QA75.5-76.95 ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,machine learning ,Drug development ,030220 oncology & carcinogenesis ,Liver damage ,Artificial intelligence ,lcsh:Electronic computers. Computer science ,business ,drug-induced liver injury - Abstract
Drug-induced liver injury (DILI) is a common reason for the withdrawal of a drug from the market. Early assessment of DILI risk is an essential part of drug development, but it is rendered challenging prior to clinical trials by the complex factors that give rise to liver damage. Artificial intelligence (AI) approaches, particularly those building on machine learning, range from random forests to more recent techniques such as deep learning, and provide tools that can analyze chemical compounds and accurately predict some of their properties based purely on their structure. This article reviews existing AI approaches to predicting DILI and elaborates on the challenges that arise from the as yet limited availability of data. Future directions are discussed focusing on rich data modalities, such as 3D spheroids, and the slow but steady increase in drugs annotated with DILI risk labels.
- Published
- 2021
- Full Text
- View/download PDF